Kalvista Company Profile
What is the competitive landscape for KALVISTA
KALVISTA has one approved drug.
There are eight US patents protecting KALVISTA drugs.
Summary for Kalvista
| US Patents: | 8 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Kalvista
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kalvista | EKTERLY | sebetralstat | TABLET;ORAL | 219301-001 | Jul 3, 2025 | RX | Yes | Yes | 11,001,578 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| Kalvista | EKTERLY | sebetralstat | TABLET;ORAL | 219301-001 | Jul 3, 2025 | RX | Yes | Yes | 11,198,691 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Kalvista | EKTERLY | sebetralstat | TABLET;ORAL | 219301-001 | Jul 3, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Kalvista | EKTERLY | sebetralstat | TABLET;ORAL | 219301-001 | Jul 3, 2025 | RX | Yes | Yes | 10,611,758 | ⤷ Start Trial | ⤷ Start Trial | ||||
| Kalvista | EKTERLY | sebetralstat | TABLET;ORAL | 219301-001 | Jul 3, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | |||||
| Kalvista | EKTERLY | sebetralstat | TABLET;ORAL | 219301-001 | Jul 3, 2025 | RX | Yes | Yes | 11,230,537 | ⤷ Start Trial | Y | Y | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Kalvista Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Poland | 3716952 | ⤷ Start Trial |
| Japan | 6995101 | ⤷ Start Trial |
| Denmark | 3224256 | ⤷ Start Trial |
| Slovenia | 3464265 | ⤷ Start Trial |
| Mexico | 386113 | ⤷ Start Trial |
| Serbia | 59395 | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Kalvista Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 3224256 | 122026000006 | Germany | ⤷ Start Trial | PRODUCT NAME: SEBETRALSTAT ODER EIN PHARMAZEUTISCH UNBEDENKLICHES SALZ ODER SOLVAT DAVON; AUTHORISATION NO/DATE: EU/1/25/1975 20250917 |
| 3224256 | 301364 | Netherlands | ⤷ Start Trial | PRODUCT NAME: SEBETRALSTAT OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT OF SOLVAAT DAARVAN; REGISTRATION NO/DATE: EU/1/25/1975 20250918 |
| 3224256 | 50005/2026 | Austria | ⤷ Start Trial | PRODUCT NAME: SEBETRALSTAT ODER EIN PHARMAZEUTISCH VERTRAEGLICHES SALZ ODER SOLVAT DAVON; REGISTRATION NO/DATE: EU/1/25/1975 (MITTEILUNG) 20250918 |
| 3224256 | LUC50033 | Luxembourg | ⤷ Start Trial | PRODUCT NAME: SEBETRALSTAT OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF; AUTHORISATION NUMBER AND DATE: EU/1/25/1975 20250917 |
| 3224256 | 202640002 | Slovenia | ⤷ Start Trial | PRODUCT NAME: SEBETRALSTAT OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF; NATIONAL AUTHORISATION NUMBER: EU/1/25/1975; DATE OF NATIONAL AUTHORISATION: 20250917; AUTHORITY FOR NATIONAL AUTHORISATION: EU |
| 3224256 | PA2026502 | Lithuania | ⤷ Start Trial | PRODUCT NAME: SEBETRALSTATAS ARBA JO FARMACINIU POZIURIU PRIIMTINA DRUSKA ARBASOLVATAS; REGISTRATION NO/DATE: EU/1/25/1975 20250917 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
